A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition
NCT00287066 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2008-02-21
Summary
To assess the impact of inhalation of insulin on glucose disposition in patients with type 1 diabetes
Conditions
Interventions
- DRUG
-
Inhaled Human Insulin
- DRUG
-
Regular Human Insulin
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-02-28
- Completion
- 2007-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
NCT02703324 ·Status: COMPLETED ·Phase: PHASE1
-
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
NCT02411578 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
NCT04585776 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
NCT03056456 ·Status: COMPLETED ·Phase: PHASE1
-
Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
NCT02700048 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
NCT03490942 ·Status: TERMINATED ·Phase: PHASE2
-
Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes
NCT00922649 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
NCT02081014 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes
NCT01730014 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
NCT02660242 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump
NCT00115973 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler
NCT00426920 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of LY900014 in a Medtronic Pump
NCT03760640 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Use of a Graded Infusion of Intravenous Glucose in the Assessment of Insulin Secretion Rates (MK-0000-078)
NCT01021462 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
NCT00322257 ·Status: TERMINATED ·Phase: PHASE3
-
Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump
NCT04409587 ·Status: COMPLETED ·Phase: PHASE4
-
A Study for Patients With Type 1 Diabetes Mellitus
NCT00447213 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes
NCT01029444 ·Status: TERMINATED ·Phase: PHASE3
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes
NCT02612844 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes
NCT07305805 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose
NCT04623086 ·Status: COMPLETED ·Phase: PHASE4
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
NCT02855307 ·Status: COMPLETED ·Phase: PHASE2
-
Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus
NCT01603121 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus
NCT04599075 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
NCT05762107 ·Status: RECRUITING ·Phase: PHASE2